Biomedical Imaging Symposium Agenda

Biomedical Imaging Symposium
NIH Office of Extramural Research -

Visualizing the Future of Biology and Medicine

June 25–26, 1999

Natcher Conference Center
National Institutes of Health
Bethesda, MD

Preliminary Agenda

Friday, June 25, 1999
7:30 - 9:00 a.m.	Registration
Morning Plenary Session
9:00 - 9:10 a.m.	Opening Remarks Harold E. Varmus, M.D., Director, NIH
9:10 - 9:15 a.m.	Introduction of Plenary Speakers Claude Lenfant, M.D., Director, National Heart, Lung, and Blood Institute, NIH
9:15 - 9:45 a.m.	Challenges for the Imaging Sciences in Neurological, Cardiovascular, Musculoskeletal, and Cancerous Disorders Thomas F. Budinger, M.D., Ph.D., Lawrence Berkeley National Laboratory
9:45 - 10:15 a.m.	Therapy: Challenges for Imaging Sciences Thomas J. Brady, M.D., Massachusetts General Hospital
10:15 - 10:25 a.m.	The NIH Bioengineering Consortium Wendy Baldwin, Ph.D., Office of the Director, NIH
10:25 - 10:55 a.m.	BREAK, Posters and Exhibits
10:55 - 11:00 a.m.	Introduction of Plenary Speakers Robert E. Wittes, M.D., National Cancer Institute, NIH
11:00 - 11:30 a.m.	What the Oncologist Wants From Imaging Samuel Hellman, M.D., University of Chicago
11:30 a.m. - 12:00 p.m.	Clinical Prospects for Imaging and Managing Angiogenesis in Cancer and Atherosclerosis Samuel A. Wickline, M.D., Washington University
12:00 - 1:00 p.m.	LUNCH, Posters and Exhibits
Afternoon Plenary Session
1:00 - 2:20 p.m.	Imaging at the Cellular and Molecular Levels Henry N. Wagner, Jr., M.D., Johns Hopkins University, Co-Moderator Linda L. Otis, D.D.S., University of Connecticut, Co-Moderator Opening Remarks: Implications of Systematic Genome-Wide Analysis for Diagnosis and Natural History of Human Cancer Jeffrey M. Trent, Ph.D., National Human Genome Research Institute, NIH Design Issues for Novel Contrast Agents and Biologic Probes Thomas J. Meade, Ph.D., California Institute of Technology Optical Coherence Tomography and In Vivo Imaging James G. Fujimoto, Ph.D., Massachusetts Institute of Technology In Vivo Microscopy With Positron Emission Tomography Harvey R. Herschman, Ph.D., University of California, Los Angeles
2:20 - 2:45 p.m.	Discussion
2:45 - 3:30 p.m.	BREAK, Posters and Exhibits
3:30 - 4:15 p.m.	Panel (Panelists will discuss phenotyping, genomics, contrast mechanisms, imaging probes, imaging at the end of a catheter, imaging in association with implantable probes or biosensors, metabolic diseases, degenerative diseases, neoplasms, angiogenesis.) Katherine W. Ferrara, Ph.D., University of California, Davis Ralph Weissleder, M.D., Ph.D., Massachusetts General Hospital Helene Benveniste, M.D., Ph.D., Duke University Medical Center Daniel L. Farkas, Ph.D., University of Pittsburgh Robert F. Bonner, Ph.D., National Institute of Child Health and Human Development, NIH
4:15 - 5:30 p.m.	Discussion
5:30 p.m.	Posters and Exhibits, Report Writing, Reception
Saturday, June 26, 1999 Morning Plenary Session
8:00 - 8:15 a.m.	Opening Remarks: Biomedical Imaging as a Science in Need of Identity and Support William R. Hendee, Ph.D., President, AIMBE
8:15 - 9:15 a.m.	Imaging in the Early Detection of Disease June Taylor, Ph.D., St. Jude Children's Research Hospital, Co-Moderator Albert Macovski, Ph.D., Stanford University, Co-Moderator Ultrasound in the Early Detection of Disease Olaf von Ramm, Ph.D., Duke University Functional Imaging in the Early Detection of Disease Nora D. Volkow, M.D., Brookhaven National Laboratory Biosensors in the Early Detection of Disease Jerome S. Schultz, Ph.D., University of Pittsburgh
9:15 - 9:45 a.m.	Discussion
9:45 - 10:30 a.m.	BREAK, Posters and Exhibits
10:30 - 11:15 a.m.	Panel (Panelists will discuss temporal, spatial, and contrast resolution needs for early detection; technologies for early detection of inflammatory, metabolic, degenerative, neoplastic disease; functional imaging technologies for early detection; home monitoring; biosensors; image exploitation [automatic target recognition, artificial intelligence, image processing].) Roderic I. Pettigrew, Ph.D., M.D., Emory University Hospital Robert S. Balaban, Ph.D., National Heart, Lung, and Blood Institute, NIH Rebecca Richards-Kortum, Ph.D., University of Texas Maryellen L. Giger, Ph.D., University of Chicago Peter Basser, Ph.D., National Institute of Child Health and Human Development, NIH
11:15 a.m. - 12:00 p.m.	Discussion
12:00 - 1:00 p.m.	LUNCH, Posters and Exhibits
*Afternoon Plenary Session*
1:00 - 2:00 p.m.	Imaging in Therapy Richard L. Ehman, M.D., Mayo Clinic, Co-Moderator James F. Toole, M.D., LL.B., Wake Forest University, Co-Moderator Imaging in Therapy: Surgeon's Perspective Warren Grundfest, M.D., University of California, Los Angeles Imaging in Therapy: Radiologist's Perspective Ron Kikinis, M.D., Brigham and Women's Hospital Imaging in Therapy: Bioengineer's Perspective Sarah Nelson, Ph.D., University of California, San Francisco
2:00 - 2:30 p.m.	BREAK
2:30 - 3:15 p.m.	Panel (Panelists will discuss monitoring the effects of therapy, imaging in rational drug/therapy development, site-specific drug delivery, gene therapy, minimally invasive procedures, robotics, image fusion, registration, and visualization.) Russell H. Taylor, Ph.D., Johns Hopkins University Michael E. Phelps, Ph.D., University of California, Los Angeles Kullervo Hynynen, Ph.D., Harvard Medical School Yoram Rudy, Ph.D., Case Western Reserve University Richard A. Robb, Ph.D., Mayo Foundation/Clinic
3:15 - 4:00 p.m.	Discussion
4:00 p.m.	Report Writing

web posting: 99/01/12
Webmaster